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Abstract 
Tart Montmorency cherry concentrate (MC) has been reported to attenuate the symptoms of 
exercise-induced muscle damage (EIMD) and to accelerate exercise recovery, which has been 
attributed to its high anti-inflammatory and antioxidant properties. Although these data are 
promising, there are no data regarding exclusively female populations. Therefore, the aim of 
this investigation was to examine the efficacy of MC on recovery following EIMD in females. 
In a randomised, double-blind, placebo-controlled study, twenty physically active females 
(mean ± SD age 19 ± 1 y; stature 167 ± 6 cm; body mass 61.4 ± 5.7 kg) consumed MC or a 
placebo (PL) for eight days (30 mL twice per day). Following four days of supplementation, 
participants completed a repeated-sprint protocol and measures of muscle soreness (DOMS), 
pain pressure threshold (PPT), limb girth, flexibility, muscle function, and systemic indices of 
muscle damage and inflammation were collected pre, immediately post (0 h) and 24, 48 and 
72 h post-exercise. Time effects were observed for all dependent variables (p<0.05) except 
limb girth and high sensitivity C-reactive protein. Recovery of countermovement jump height 
was improved in the MC group compared to PL (p=0.016). There was also a trend for lower 
DOMS (p=0.070) and for higher PPT in the MC group at the rectus femoris (p=0.071). The 
data demonstrate that MC supplementation may be a practical nutritional intervention to help 
attenuate the symptoms of muscle damage and improve recovery on subsequent days in 
females.  
Key words 
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Introduction 
Initial muscle damage is thought to be caused by a combination of mechanical disruption to 
the myofibrils and oxidative stress; the latter owing to an increase in the production of reactive 
oxygen and nitrogen species (RONS) and nitric oxide (NO) derivatives which may exceed 
antioxidant capacity (Powers & Jackson, 2008). Moreover, the secondary inflammatory 
response to muscle injury involves the degradation of damaged muscle by immune cells which 
release pro-inflammatory cytokines and further RONS and NO derivatives; exacerbating 
muscle damage (Clarkson & Hubal, 2002). The role of RONS and NO derivatives in the 
oxidative stress, inflammatory, and muscle damage responses which manifest during and 
following exercise has raised substantial interest in antioxidant supplementation. Of particular 
interest is tart Montmorency cherry concentrate (MC), which has been proposed to be an 
effective recovery aid due to its high anti-inflammatory and antioxidant properties (Bell et al., 
2014; Bell et al., 2015; Keane et al., 2015a; Kirakosyan et al., 2015; Seeram et al., 2001; Wang 
et al., 1999). Montmorency tart cherries and their derivatives contain numerous polyphenols 
that include flavonoids; for example, the flavonol quercetin and anthocyanins (Kim et al., 2005; 
Kirakosyan et al., 2009). Certainly, the polyphenolic compounds that MC contain result in 
higher oxygen radical absorbance capacity (ORAC) values compared to several other 
antioxidant beverages such as Concord grape, acai, and blueberry juice (Bell et al., 2013; 
Howatson et al., 2010; Seeram et al., 2008).  
To date, research in exercise and recovery paradigms has demonstrated that MC can improve 
recovery from damaging bouts of exercise in isolated muscle groups by attenuating decrements 
in muscle strength and/or soreness and pain (Bowtell et al., 2011; Connolly et al., 2006; Levers 
et al., 2015). Additionally, following damaging running activity, research has identified MC to 
be beneficial in reducing pain (Kuehl et al., 2010) and improving indices of inflammation, 
oxidative stress, antioxidant status and muscle function (Howatson et al., 2010). More recently, 
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MC has also been shown to facilitate recovery following cycling (Bell et al., 2014; Bell et al., 
2015) and an adapted Loughborough Intermittent Shuttle Test (LIST) protocol (Bell et al., 
2016).  
Collectively, these lines of investigation have application to athletic populations that would 
benefit from reduced symptoms of muscle damage following strenuous activity. However, the 
effects of MC beyond isolated muscle, running and cycling activity are limited, and 
conceptually other sports and activities could benefit from this intervention. In addition, whilst 
females have been included in mixed-sex populations (Howatson et al., 2010; Kuehl et al., 
2010), there are no data regarding exclusively female populations, largely due to the potential 
for oestrogen to influence outcome variables (Kendall & Eston, 2002). A growing body of 
evidence suggests that oestrogen has antioxidant properties (Tiidus et al., 2005; Wolf et al., 
2012) and may help to maintain muscle membrane integrity consequent to muscle damage. As 
a result, the initial physiological stress and ensuing recovery associated with exercise-induced 
muscle damage (EIMD) in females is likely to differ compared to male populations. Indeed, 
recent evidence suggests that EIMD and recovery may differ between menstrual cycle phases 
given the fluctuating oestrogen concentrations (Markofski & Braun, 2014). Moreover, given 
their structural similarities to oestrogen, polyphenolic secondary plant metabolites (including 
the flavonoids that MC contains) appear to exert oestrogenic effects (Miksicek, 1995), and thus 
modulate and affect the bioavailability of endogenous oestrogens (Ward & Kuhnle, 2010). As 
such, since oestrogen is thought to play a key role in the observed sex differences in EIMD, 
currently the lack of studies investigating the supplementation of MC in a female only 
population is surprising and warrants research.  
Therefore, the aim of this investigation was to examine the efficacy of MC on recovery from 
EIMD in females. It was hypothesised that indices of EIMD would be attenuated by the 
consumption of MC.  
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Methods 
Participants 
Twenty physically active females (mean ± SD age 19 ± 1 y; stature 167 ± 6 cm; body mass 
61.4 ± 5.7 kg; BMI 22.1 ± 1.9 kg·m-2) were recruited from a university dance team and gave 
written informed consent. The sample size was determined by completing a power analysis 
(power=0.8, α=0.05) based on isometric strength data from Bowtell et al. (2011). This 
determined a sample size of five in each group would provide statistical power above 80%, 
with an alpha level of 0.05. Exclusion criteria were; epilepsy, bronchitis, severe asthma, cardiac 
complaints, bacterial or viral infection in the 2 weeks preceding, injury or recovering from an 
injury sustained in the preceding 4 weeks, pregnancy, food allergy relating to the study 
supplements (as discussed with the investigator), or anything that may prevent them from 
successfully completing the study that was described. Participants had been training in dance 
regularly for 13 ± 4 years and were currently exercising for 8.3 ± 5 h per week; with no 
significant differences between groups (independent samples t-test p=0.567 and p=0.598, 
respectively). A single self-reported menstrual cycle questionnaire (as used previously by 
Brown et al., 2016a) identified the current contraceptive use of participants; nine were using 
an oral combination pill (all monophasic; n=6 in Montmorency cherry concentrate (MC) group 
and n=3 in placebo (PL) group), six were using a progesterone only pill/implant/injection (n=3 
in both MC and PL groups), and five were menstruating normally (n=1 in MC group and n=4 
in PL group). This also estimated menstrual cycle phase and allowed testing days to be 
assigned; all data collection took place during the early to mid-luteal phase, or where applicable 
in the 14 days before a withdrawal bleed. For 24 h prior to, and for each of the testing days, 
participants were asked to avoid strenuous exercise, alcohol, caffeine, nutritional supplements, 
and any anti-inflammatory drugs or alternative treatments. Participants completed a weighed 
food diary (analysed using dietary analysis software (Nutritics Ltd, Swords, Ireland)) and 
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activity log throughout all trial periods. Aside from the restrictions outlined previously, 
participants were not restricted in their consumption of polyphenolic rich foods and were 
instructed to consume their habitual diets. However, portions of foods thought to contain 
antioxidants were totalled for each day and averaged across the experimental period (Howatson 
et al., 2012; Howatson et al., 2010). The study was conducted according to the guidelines of 
the Declaration of Helsinki and all experimental procedures were approved by the Faculty of 
Health and Life Sciences Ethics Committee at the University of Northumbria.  
Experimental protocol 
Participants were allocated to either tart Montmorency cherry concentrate (MC; n=10) or 
placebo (PL; n=10) supplementation in a double-blind manner using stratified randomisation 
to ensure that groups were matched and counterbalanced for muscle function. A pre-
supplementation blood sample (baseline) was taken in order to detect any changes in total 
creatine kinase (CK) and high sensitivity C-reactive protein (hsCRP) with preload 
supplementation. Participants fasted for ≥10 h prior to each visit, except for water (consumed 
ad libitum) and the morning supplement. On arrival at the laboratory, baseline measures of 
dependant variables were recorded. Participants completed the exercise protocol, and after a 2 
min rest, measurement of dependent variables was repeated. Before leaving the laboratory, 
participants were reminded to consume a supplement prior to their evening meal. 
Supplementation and measurement of dependent variables were then repeated at the same time 
of day (± 1 h) for the following 3 days (24, 48 and 72 h post EIMD). 
Supplementation 
Participants consumed their habitual diets during all trial periods. Participants were provided 
with eight days of supplementation along with instructions on ingestion frequency and timing. 
This period was for four days prior to muscle-damaging exercise, the day of exercise, and for 
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three days of recovery. The daily dose was two servings of the MC or PL; one dose taken prior 
to breakfast (or 1-2 h prior to laboratory visits), and one dose prior to evening meal (except for 
the final day where only one supplement was consumed before the final visit). This is based on 
previous work showing a positive effect on recovery following strenuous exercise (Bell et al., 
2016; Bell et al., 2014; Bell et al., 2015).  
The MC beverage was prepared with 30 mL of concentrate (CherryActive, Sunbury, UK) 
diluted in 100 mL of water. According to the manufacturer’s information, a 30 mL dose of 
concentrate is equivalent to approximately 90 whole cherries and has been previously reported 
to contain a total anthocyanin content of 73.5 mg·L−1 of cyanidin-3-glucoside, a total phenolic 
content of 178.8 gallic acid equivalent·L−1 and an antioxidant capacity (TEAC) of 0.58 trolox 
equivalents·L−1 (Keane et al., 2016).  The PL was prepared with 25 mL of a synthetically 
derived fruit flavoured concentrate with negligible phytochemical content (Kia-Ora, Uxbridge, 
UK) in 100 mL of water and was fortified with flavourless maltodextrin (Myprotein, 
Manchester, UK) and flavourless whey protein powder (Arla Foods, Amba, Denmark). This 
was in order to match test beverages as closely as possible for volume (130 ml), consistency, 
colour, and macronutrient (24.5 g carbohydrate and 1.1 g protein) and energy content (102 kcal 
and 103 kcal for the MC and PL beverages, respectively).   
Exercise protocol 
Following a standardised warm up, participants completed a repeated-sprint protocol which 
comprised 15 x 30 m maximal sprints with a rapid 10 m deceleration phase, each separated by 
60 s rest (Brown et al., 2016a; Brown et al., 2016b; Howatson & Milak, 2009; Keane et al., 
2015b). Rate of perceived exertion (RPE; Borg, (1982)) and heart rate (HR; Model RS-400, 
Polar, Kempele, Finland) were collected after each sprint effort. Sprint times were recorded 
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using timing gates (Brower telemetric timers, Brower timing systems, Draper, USA) to 
determine total sprint time, mean sprint time, and rate of fatigue (Fitzsimons et al., 1993).  
 
Dependant variables 
Muscle soreness 
Subjective ratings of muscle soreness (DOMS) were measured using a 200 mm visual analogue 
scale. Participants were required to indicate the level of perceived active lower limb soreness 
felt during a 900 squat. Pain pressure threshold (PPT) was measured with a digital algometer 
(Model FDX, Wagner Instruments, Greenwich, USA) at three muscle locations on the right 
leg; the rectus femoris (RF), the vastus lateralis (VL), and medial head of the gastrocnemius 
(GM) (Clifford et al., 2016). To determine PPT, participants were asked to verbally indicate 
when the pressure applied to the muscle (at an approximate rate of 5 N·s-1) became too 
uncomfortable to tolerate. Intra-trial and inter-trial percentage coefficient of variation (%CV) 
were <8% for all locations.  
Limb girth 
An anthropometric tape measure (Bodycare Products, Warwickshire, United Kingdom) was 
used to determine calf (measured at its largest girth at baseline) and mid-thigh (located as 
midway between the inguinal fold and the superior border of the patella) girths of the right leg. 
Calf and mid-thigh girth intra-examiner %CVs were <1%. 
Flexibility 
Hamstring stiffness and flexibility was measured using the sit and reach test. The knees were 
fully extended with the feet together against the sit and reach box. Participants were instructed 
to stretch as far as possible (but not to the point of pain) and to hold their ‘best stretch’ for 
 9 
approximately 2 s (American College of Sports Medicine, 2013) (recorded to the nearest 0.5 
cm). Intra-trial and inter-trial %CV were <5%. 
 
Muscle function 
Participants completed three countermovement jumps (CMJ) and three drop jumps (for 
measurement of reactive strength index (RSI)) using a light timing system (Optojump, 
Microgate, Bolzano, Italy), keeping their hands on their hips throughout. For CMJ, participants 
were asked to squat down and jump vertically and maximally. For RSI (jump height (cm) ÷ 
ground contact time (s)), participants were instructed to drop from a height of 30 cm and upon 
landing, to perform a two-footed jump maximally with minimum contact time. Each effort was 
separated by 60 s rest and the peak CMJ and RSI were used for analysis. Intra-trial and inter-
trial %CV were both <4% and <12% for CMJ and RSI respectively. 
Maximum voluntary isometric contraction (MVC) of the right knee extensors was measured 
using a strain gauge (MIE Digital Myometer, MIE Medical Research Ltd, Leeds, UK). While 
in a seated position, the knee joint angle was standardised at 900 of flexion before each 
contraction. The peak force (Newtons, N) of three MVCs (of 3 s duration interspersed with 30 
s rest) was used for analysis. Intra-trial and inter-trial %CV were <4%.    
Participants completed a single maximal effort 30 m sprint, and sprint time was recorded 
(Brower telemetric timers, Brower timing systems, Draper, USA). Both intra-trial and inter-
trial %CV were <2%.   
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Blood sampling and analysis 
Blood samples (10 mL) were collected via venepuncture from the antecubital fossa area into 
serum gel vacutainers. Samples were rested at room temperature for 20 min, and centrifuged 
for 15 min (4˚C) at 3000 RCF (Allegra X-22 Centrifuge, Beckman Coulter, Bucks, UK). 
Aliquots of serum were stored at -80°C for later analysis of CK and hsCRP; determined 
spectrophotometrically using an automated system (Roche Modular, Roche Diagnostics, 
Burgess Hill, UK). Due to technical issues, 5 blood samples (<5%) were not collected. When 
lower detection limits were not reached for hsCRP, the lowest detectable concentration was 
used (0.15 mg·L-1). Inter-assay and intra-assay %CV for both total CK and hsCRP were <9%. 
Statistical analysis 
For the purpose of data analysis, all dependant variables except for DOMS, CK and hsCRP are 
expressed as a percentage relative to pre muscle damage values to account for inter-individual 
variability. Statistical software (IBM Statistical Package for Social Sciences (SPSS) V22 IBM, 
Armonk, USA) was used for inferential analysis and statistical significance accepted at the 
p≤0.05 level a priori. Mixed factor repeated-measures analysis of variance were performed for 
each dependent variable. Mauchly’s test assessed the sphericity of the data and, where 
appropriate, violations were corrected using the Greenhouse–Geisser correction. Significant 
main effects were analysed using the Least Significant Difference test for adjustment for 
multiple comparisons. Paired samples t-tests were conducted to assess differences between 
total CK and hsCRP levels pre-supplementation (baseline) and pre-exercise, in order to detect 
any changes in systemic indices with preload supplementation. Independent samples t-tests 
were conducted on peak HR, peak RPE, fatigue, and total and mean sprint time to examine 
differences in exercise intensity during the repeated-sprint protocol between groups. Where 
appropriate, Cohen’s d effect sizes (ES) were calculated with the magnitude of effects 
considered small (0.2), moderate (0.5) and large (>0.8). 
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Results 
There were no differences in the total energy intake and macronutrient intake presented as a 
percentage of total energy intake (all p>0.05, ES>0.47), and the number of portions of foods 
containing antioxidants consumed by participants in both treatment groups (6 ± 2 in both MC 
and PL groups; p=0.731) during the supplementation period. Following all data collection 
periods, only n=4 participants correctly identified which supplement they had consumed. There 
were no differences between MC and PL groups for total (80.74 ± 4.02 vs 81.69 ± 3.67 s) and 
mean (5.38 ± 0.27 vs 5.45 ± 0.24 s) sprint time, fatigue (5.23 ± 2.02 vs 4.54 ± 2.16%), peak 
HR (176 ± 15 vs 178 ± 8 bpm), and peak RPE (17 ± 2 vs 18 ± 1) during the repeated-sprint 
protocol (all p>0.05); demonstrating that the exercise stimulus was comparable between 
groups. All raw data not illustrated in figures are presented in Table 1.  
Table 1. Values for dependent variables in response to muscle-damaging exercise, mean ± 
SD. 
Variable Group 
Time post muscle-damaging exercise (h) 
Pre 0 24 48 72 
RF PPT, 
N 
MC  48.1 ± 8.8  46.9 ± 11.6 42.5 ± 10.8 48.7 ± 12.9 56.0 ± 17.5 
 PL 35.2 ± 12.4 30.8 ± 10.6  25.9 ± 6.9 28.7 ± 10.0  35.1 ± 8.8 
VL PPT, 
N 
MC  42.6 ± 9.8 47.3 ± 18.0 34.9 ± 13.6 41.6 ± 12.6 53.3 ± 23.3 
 PL 30.2 ± 10.1 29.7 ± 11.8 25.5 ± 7.2 28.5 ± 10.2 32.5 ± 10.5 
GM PPT, 
N 
MC 41.4 ± 11.2 42.4 ± 15.5 31.8 ± 8.8 39.4 ± 9.4 50.2 ± 12.2 
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 PL 27.3 ± 12.1 25.0 ± 12.1 21.9 ± 8.7 24.9 ± 10.2 30.1 ± 9.9 
Thigh 
girth, cm 
MC 50.1 ± 3.1 50.4 ± 3.0 50.3 ± 3.0 50.3 ± 3.0 50.3 ± 2.8 
PL 50.6 ± 2.2 50.9 ± 2.6 51.0 ± 2.4 51.0 ± 2.5 50.9 ± 2.4 
Calf girth, 
cm 
MC 36.1 ± 2.3 36.2 ± 2.4 36.1 ± 2.4 36.1 ± 2.3 36.2 ± 2.2 
PL 36.2 ± 2.1 36.1 ± 1.9 36.2 ± 2.0 36.2 ± 2.2 36.2 ± 2.0 
Flexibility
, cm 
MC 29.1 ± 5.4 28.3 ± 6.4 25.0 ± 7.2 26.4 ± 9.3 29.0 ± 7.8 
 PL 20.3 ± 9.0 17.7 ± 9.0 14.5 ± 6.1 17.4 ± 8.3 17.6 ± 9.0 
RSI, cm·s-
1 
MC 102.8 ± 
22.5 
88.6 ± 21.5 97.2 ± 28.5 99.0 ± 22.2 
 107.0 ± 
27.1 
 PL 81.5 ± 17.6 74.7 ± 13.7 72.0 ± 13.8 73.0 ± 14.4 80.2 ± 20.1 
MVC, N  MC 394.3 ± 
59.3 
347.1 ± 
82.5 
362.7 ± 
87.1 
381.3 ± 
87.2 
376.5 ± 
73.6 
 PL 392.2 ± 
89.4 
354.1 ± 
72.7 
355.4 ± 
73.8 
361.8 ± 
70.2 
375.9 ± 
63.9 
30 m 
sprint 
time, s 
MC 
5.32 ± 0.35 5.42 ± 0.36 5.39 ± 0.31 5.45 ± 0.29 5.37 ± 0.40 
 PL 5.28 ± 0.26 5.46 ± 0.30 5.37 ± 0.27 5.58 ± 0.41 5.43 ± 0.29 
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hsCRP, 
mg·L-1 
MC 
1.63 ± 1.99 1.79 ± 1.87 2.15 ± 0.24 2.13 ± 1.97 1.56 ± 1.35 
 PL 1.81 ± 1.93 1.80 ± 1.87 1.73 ± 1.73 1.29 ± 1.14 1.71 ± 1.31 
MC, Montmorency cherry group (n=10); PL, placebo group (n=10); Pre, pre-exercise; RF, 
rectus femoris; VL, vastus lateralis; GM, medial head of the gastrocnemius; PPT, pain pressure 
threshold; CMJ, countermovement jump; RSI, reactive strength index; MVC, maximal 
voluntary isometric contraction; hsCRP, high sensitivity C-reactive protein.  
 
Muscle soreness increased post-exercise (p<0.001), peaking at 24 h and remained elevated 
throughout recovery in both groups (Figure 1); however, there was a trend and moderate effect 
for lower DOMS in the MC group (p=0.070, ES=0.58). At all three locations, PPT was reduced 
post-exercise (all p<0.001), reached lowest levels at 24 h and then increased throughout 
recovery. There were no group differences in PPT at the VL or GM, but a trend and moderate 
effect for higher PPT in the MC group at the RF was observed (p=0.071, ES=0.59). 
 
Figure 1 Muscle soreness (DOMS) post exercise-induced muscle damage in the Montmorency cherry (MC) (n=10) and 
placebo (PL) (n=10) groups. Values presented as mean ± SD. 
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Thigh and calf girths were unaffected post-exercise and there were no differences between 
treatment groups (all p>0.05).  Flexibility was reduced for 48 h post-exercise but returned to 
baseline levels at 72 h in both groups (p=0.022) with no group differences.  
All measures of muscle function (CMJ, RSI, MVC and 30 m sprint time) were reduced post-
exercise and progressively recovered throughout recovery (all p<0.05). While recovery of these 
measures appeared to accelerate with MC, a group effect was only evident with CMJ (p=0.016, 
ES=0.66) (Figure 2).  
 
Figure 2 Percentage relative to pre-exercise (Pre) countermovement jump height (CMJ) post exercise-induced muscle 
damage in the Montmorency cherry (MC) (n=10) and placebo (PL) (n=10) groups. Values presented as mean ± SD. 
*denotes significantly higher CMJ in MC. 
Total CK and hsCRP concentrations were not different between baseline and pre-exercise time-
points for both MC and PL groups (all p>0.05). Both groups experienced an increase in 
circulating CK, which peaked 24 h post-exercise and remained elevated for 72 h post-exercise 
(p<0.001) with no differences between groups (Figure 3). Circulating hsCRP was unaffected 
by exercise and was not different between groups.  
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Figure 3 Total creatine kinase (CK) at baseline pre-supplementation (BL), before (Pre) and post exercise-induced muscle 
damage in the Montmorency cherry (MC) (n=10) and placebo (PL) groups (n=10). Values presented as mean ± SD. 
 
Discussion 
This study sought to examine the efficacy of 8-day MC supplementation on recovery from 
EIMD in females. The data demonstrate that MC supplementation accelerated the recovery of 
CMJ and was associated with trends of reduced muscle soreness.  
The clear acceleration in recovery of CMJ following MC supplementation supports a recent 
study demonstrating an improvement in CMJ (Bell et al., 2016), and a number of studies 
demonstrating an accelerated recovery in other measures of muscle function with MC 
consumption (Bell et al., 2015; Bowtell et al., 2011; Connolly et al., 2006; Howatson et al., 
2010). The improvement of CMJ with MC may be explained by a protection against oxidative 
injury to the type II fibres recruited for such activity. Eccentric exercise is thought to 
preferentially damage type II muscle fibres (Macaluso et al., 2012) and this has implications 
on the muscles’ force-generating capacity (Byrne et al., 2004). Interestingly, evidence suggests 
that mitochondrial ROS production and/or release is potentiated in type II fibres (Anderson & 
Neufer, 2006) and the activity of endogenous antioxidant enzymes including superoxide 
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dismutase (SOD) (Criswell et al., 1993; Powers et al., 1994) and glutathione peroxidase (GPX) 
(Lawler et al., 1994; Powers et al., 1994) are lower compared with type I fibres in rodent 
models. During periods of increased oxidant production (for instance intense exercise), both 
enzymatic and non-enzymatic antioxidants collectively provide some protection to muscle 
fibres from oxidative injury (Powers & Jackson, 2008). Therefore, conceptually the 
supplementation of non-enzymatic antioxidants contributed to the free radical scavenging 
capacity of type II fibres and facilitated recovery of CMJ. However, the functional measures 
in the present investigation all require type II fibre recruitment, so intuitively, we would have 
expected the measures to be equally affected by MC. Indeed, the lack of an accelerated 
recovery of MVC with MC is in contrast to a number of previous studies (Bell et al., 2015; 
Bowtell et al., 2011; Connolly et al., 2006; Howatson et al., 2010). Certainly, the role of MC 
in accelerating the recovery of muscle function in this population following EIMD in the 
current study remains unclear.   
Supplementation with MC resulted in a moderate effect for reductions in DOMS and increases 
in PPT at the RF; which could have played a role in the observed improvements in CMJ. This 
is in line with a number of investigations reporting reduced soreness and pain with MC 
supplementation (Bell et al., 2016; Connolly et al., 2006; Kuehl et al., 2010; Levers et al., 
2015). However, these reductions previously reported have not always been accompanied with 
improvements in muscle function, and vice versa (Bell et al., 2015; Bowtell et al., 2011; Levers 
et al., 2015), and others have found no reduction in DOMS with MC consumption (Bell et al., 
2015; Bowtell et al., 2011; Howatson et al., 2010). The inconsistencies in the literature could 
be explained by the disparities in exercise protocol employed. Indeed, muscle soreness has 
been associated with increases in inflammation following exercise (Kraemer et al., 2004). In 
the current investigation, hsCRP was not different between groups, and limb girth (an indirect 
measure of inflammation, swelling and oedema (Smith, 1991)) was unaffected by the exercise. 
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Compared to marathon running (Howatson et al., 2010) and high intensity cycling exercise 
(Bell et al., 2015), where CRP has been shown to increase 24 and 48 h post-exercise, the 
repeated-sprint protocol does not appear to induce a large inflammatory response. It is 
conceivable that the exercise stimulus was insufficient to detect larger magnitudes of change 
in soreness and PPT with MC. Similarly, the CK values elicited by the exercise protocol in the 
current study are lower than other damaging protocols, suggesting a moderate muscle damage 
response, and likely influencing the ability to demonstrate differences. In addition, females 
have been shown to demonstrate lower basal circulating concentrations of CK, and a lower CK 
response following exercise compared to males (Wolf et al., 2012), owing in part to the 
antioxidant properties of oestrogen (Tang, Abplanalp, Ayres, & Subbiah, 1996).  
The data which demonstrate no group differences in hsCRP and CK do not wholly support the 
literature which traditionally suggests attenuated symptoms of EIMD with MC is attributable 
to reduced muscle damage and inflammation; at least following repeated-sprint exercise in 
females. However, the current study was limited by a lack of measurement of oxidative stress 
and antioxidant capacity. Indeed, some have identified differences in oxidative stress and 
antioxidant status following strenuous exercise with supplementation of MC compared to PL 
(Bell et al., 2014; Bowtell et al., 2011; Howatson et al., 2010). It is possible that this is 
magnified in females given that oestrogen is also thought to have antioxidant properties (Tiidus 
et al., 2005; Wolf et al., 2012) as oestrogens, similar to vitamin E, display a hydroxyl group on 
their phenolic ring (Tiidus et al., 2001). It is thought that oestrogen donates the hydrogen atom 
to lipid peroxyl radicals, limiting lipid peroxidation in the cell membrane (Kendall & Eston, 
2002). Perhaps enhanced antioxidant status and redox balance may have contributed to the 
improvements in CMJ and trends in reduced soreness observed with MC in this study. Future 
research should include measurement of a variety of systemic indices to provide greater insight 
into specific mechanisms influencing improved muscle function and pain with MC. Moreover, 
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more accurate determination of menstrual cycle phase (urine ovulation prediction tests for 
example) and measurement of concentrations of oestrogen (particularly of oestradiol) in female 
participants is warranted to assist with the interpretation of results.   
This study demonstrated that 8-day MC supplementation alongside a habitual diet improved 
recovery of CMJ and tended to lower muscle soreness compared to PL. This research adds to 
the existing body of knowledge whilst providing new information for the potential application 
of MC to wider groups. In particular, it would appear that female populations might benefit 
from this nutritional intervention to help attenuate the symptoms of EIMD and improve 
recovery on subsequent days. 
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